BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20362724)

  • 1. Quantitative myocardial blush grade for the detection of cardiac allograft vasculopathy.
    Korosoglou G; Riedle N; Erbacher M; Dengler TJ; Zugck C; Rottbauer W; Hardt S; Bekeredjian R; Kristen A; Giannitsis E; Osman NF; Dickhaus H; Katus HA
    Am Heart J; 2010 Apr; 159(4):643-651.e2. PubMed ID: 20362724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome after heart transplantation predicted by quantitative myocardial blush grade in coronary angiography.
    Hofmann NP; Voss A; Dickhaus H; Erbacher M; Doesch A; Ehlermann P; Gitsioudis G; Buss SJ; Giannitsis E; Katus HA; Korosoglou G
    Am J Transplant; 2013 Jun; 13(6):1491-502. PubMed ID: 23617734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial Perfusion Reserve and Strain-Encoded CMR for Evaluation of Cardiac Allograft Microvasculopathy.
    Erbel C; Mukhammadaminova N; Gleissner CA; Osman NF; Hofmann NP; Steuer C; Akhavanpoor M; Wangler S; Celik S; Doesch AO; Voss A; Buss SJ; Schnabel PA; Katus HA; Korosoglou G
    JACC Cardiovasc Imaging; 2016 Mar; 9(3):255-66. PubMed ID: 26965729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early assessment of infarct size and prediction of functional recovery by quantitative myocardial blush grade in patients with acute coronary syndromes treated according to current guidelines.
    Riedle N; Dickhaus H; Erbacher M; Steen H; Andrassy M; Lossnitzer D; Hardt S; Rottbauer W; Zugck C; Giannitsis E; Katus HA; Korosoglou G
    Catheter Cardiovasc Interv; 2010 Oct; 76(4):502-10. PubMed ID: 20882653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain-encoded cardiac magnetic resonance for the evaluation of chronic allograft vasculopathy in transplant recipients.
    Korosoglou G; Osman NF; Dengler TJ; Riedle N; Steen H; Lehrke S; Giannitsis E; Katus HA
    Am J Transplant; 2009 Nov; 9(11):2587-96. PubMed ID: 19843034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic Resonance for Noninvasive Detection of Microcirculatory Disease Associated With Allograft Vasculopathy: Intracoronary Measurement Validation.
    Mirelis JG; García-Pavía P; Cavero MA; González-López E; Echavarria-Pinto M; Pastrana M; Segovia J; Oteo JF; Alonso-Pulpón L; Escaned J
    Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):571-8. PubMed ID: 25522835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship among epicardial coronary disease, tissue myocardial perfusion, and survival in heart transplantation.
    Potluri SP; Mehra MR; Uber PA; Park MH; Scott RL; Ventura HO
    J Heart Lung Transplant; 2005 Aug; 24(8):1019-25. PubMed ID: 16102436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of myocardial tissue loss by quantitative densitometric myocardial blush parameters following ST-elevation myocardial infarction.
    Sasi V; Gavallér H; Kalapos A; Domsik P; Nagy FT; Ungi T; Ungi I; Forster T; Nemes A
    Acta Physiol Hung; 2015 Jun; 102(2):206-15. PubMed ID: 26100310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy.
    Miller CA; Sarma J; Naish JH; Yonan N; Williams SG; Shaw SM; Clark D; Pearce K; Stout M; Potluri R; Borg A; Coutts G; Chowdhary S; McCann GP; Parker GJ; Ray SG; Schmitt M
    J Am Coll Cardiol; 2014 Mar; 63(8):799-808. PubMed ID: 24355800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial perfusion reserve and global longitudinal strain as potential markers of coronary allograft vasculopathy in late-stage orthotopic heart transplantation.
    Narang A; Blair JE; Patel MB; Mor-Avi V; Fedson SE; Uriel N; Lang RM; Patel AR
    Int J Cardiovasc Imaging; 2018 Oct; 34(10):1607-1617. PubMed ID: 29728952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative myocardial contrast echocardiography: a new method for the non-invasive detection of chronic heart transplant rejection.
    Rutz T; de Marchi SF; Roelli P; Gloekler S; Traupe T; Steck H; Eshtehardi P; Cook S; Vogel R; Mohacsi P; Seiler C
    Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1187-94. PubMed ID: 23612502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semi-quantitative myocardial perfusion MRI in heart transplant recipients at rest: repeatability in healthy controls and assessment of cardiac allograft vasculopathy.
    DeSa TB; Abbasi MA; Blaisdell JA; Lin K; Collins JD; Carr JC; Markl M
    Clin Imaging; 2020 May; 61():62-68. PubMed ID: 31981959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET assessment of myocardial perfusion reserve inversely correlates with intravascular ultrasound findings in angiographically normal cardiac transplant recipients.
    Wu YW; Chen YH; Wang SS; Jui HY; Yen RF; Tzen KY; Chen MF; Lee CM
    J Nucl Med; 2010 Jun; 51(6):906-12. PubMed ID: 20484427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
    van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
    Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of coronary flow reserve in heart transplantation: a study performed with contrast-enhanced echocardiography.
    Osto E; Tona F; Angelini A; Montisci R; Ruscazio M; Vinci A; Tarantini G; Ramondo A; Gambino A; Thiene G; Caforio AL; Gerosa G; Iliceto S
    J Heart Lung Transplant; 2009 May; 28(5):453-60. PubMed ID: 19416773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late gadolinium enhancement assessed by cardiac magnetic resonance imaging in heart transplant recipients with different stages of cardiac allograft vasculopathy.
    Braggion-Santos MF; Lossnitzer D; Buss S; Lehrke S; Doesch A; Giannitsis E; Korosoglou G; Katus HA; Steen H
    Eur Heart J Cardiovasc Imaging; 2014 Oct; 15(10):1125-32. PubMed ID: 24908664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy.
    Chih S; Chong AY; Erthal F; deKemp RA; Davies RA; Stadnick E; So DY; Overgaard C; Wells G; Mielniczuk LM; Beanlands RSB
    J Am Coll Cardiol; 2018 Apr; 71(13):1444-1456. PubMed ID: 29598865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative evaluation of myocardial blush to assess tissue level reperfusion in patients with acute ST-elevation myocardial infarction: incremental prognostic value compared with visual assessment.
    Korosoglou G; Haars A; Michael G; Erbacher M; Hardt S; Giannitsis E; Kurz K; Franz-Josef N; Dickhaus H; Katus HA; Kuecherer H
    Am Heart J; 2007 Apr; 153(4):612-20. PubMed ID: 17383301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term mortality after cardiac allograft vasculopathy: implications of percutaneous intervention.
    Agarwal S; Parashar A; Kapadia SR; Tuzcu EM; Modi D; Starling RC; Oliveira GH
    JACC Heart Fail; 2014 Jun; 2(3):281-8. PubMed ID: 24952696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between myocardial blush grades, staining, and severe microvascular damage after primary percutaneous coronary intervention a study performed with contrast-enhanced magnetic resonance in a large consecutive series of patients.
    Marra MP; Corbetti F; Cacciavillani L; Tarantini G; Ramondo AB; Napodano M; Basso C; Lacognata C; Marzari A; Maddalena F; Iliceto S
    Am Heart J; 2010 Jun; 159(6):1124-32. PubMed ID: 20569729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.